ULTOMIRIS conc perf 300 mg/3ml flac 3 ml
7680672780023
CH-67278
L04AA43
07.15.0.
Reimbursement limitations:
ULTOMIRI.PNH
Traitement des adultes atteints avec Hémoglobinurie Paroxystique Nocturne (HPN)
Avant le début du traitement, une …
1 / 3
google
Details
- Product number
- 6727802
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- ravulizumabum 300 mg, natrii dihydrogenophosphas, dinatrii phosphas, argininum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 4.6 mg.
Articles (1)
Ultomiris 300 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
4.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 4181.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2022
Authorization holder
Alexion Pharma GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 67278
- Drug name
- Ultomiris, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L04AA43
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/01/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ULTOMIRIS conc perf 300 mg/3ml flac 3 ml
- Description (DE)
- ULTOMIRIS Inf Konz 300 mg/3ml Durchstf 3 ml
- Market launch
- 16/09/2021
- Narcotic (BTM)
- No